LGR5 and gastric cancer: Even though it was demonstrated that LGR5 overexpression might contribute to the progressive clinical features and poor OS of GC patients (Zheng et al., 2013; Chen et al., 2016; Huang et al., 2016), we had no similar findings in this study.